UEG Podcast

Episode

• 
  The Future of Faecal Microbiota Transplantation (FMT) with Maria Vehreschild (UEG Podcast rewind) 28.07.2026 30mnt

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! In this episode of the UEG Talks conversation between Maria Vehreschild and Pradeep Mundre, we delve into the complexities of the faecal microbiome and the role of faecal microbiota transplantation (FMT) in treating various diseases, particularly C. difficile infections and inflammatory bowel disease (IBD). The discussion covers the historical context of FMT, its mechanisms of action, current treatment guidelines, safety considerations, and the various delivery methods. The conversation also emphasises the need for further research and the importance of professional standards in FMT practices.
• 
  Well-rounded care in functional disorders with Tim Vanuytsel (UEG Podcast rewind) 14.07.2026 30mnt

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! Functional gastrointestinal disorders, or disorder of gut-brain interaction, can be frightening to many GIs. How do I talk to the patient? What can I tell them if there is no improvement in their symptoms? How can I even explain to them what their diagnosis is, if I don’t even know it? To clear things up and provide clear points of action, our host Egle Dieninyte talked to Tim Vanuytsel from the University Hospital in Leuven, Belgium.
• 
  Leadership in crisis with Axel Dignass (UEG Podcast rewind) 30.06.2026 27mnt

  UEG Podcast is on summer holiday and re-releases published episodes that we think deserve another listen. Enjoy! In this episode, host Egle speaks with former UEG President Axel Dignass about what it takes to lead in times of crisis. Drawing on his experience during the COVID-19 pandemic, Axel reflects on the difference between being a boss and being a true leader. He shares thoughts on the value of empathy, transparency, and consistency, as well as how to build and sustain a resilient team. The conversation also touches on the challenges of going virtual, the importance of recognising team achievements, and the warning signs of toxic leadership. A must-listen for anyone looking to grow as a leader in uncertain times.
• 
  Colorectal cancer in young patients with Michael Bretthauer 16.06.2026 20mnt

  Michael Bretthauer on the real epidemiology of colorectal cancer in the under-50s: a genuine rise from a tiny baseline, the carcinoid confounder inflating the numbers, lifestyle versus genetics, why screening ages shouldn't drop yet, and the ECOPOP trials testing endoscopic resection against surgery.
• 
  MASLD with Sven Francque - Part 2 02.06.2026 28mnt

  The 2024 MASLD treatment guidelines are already changing. Pradeep Mundre and Professor Sven Francque (Antwerp), guideline co-author, cover weight-loss targets (7% and 10%), resmetirom in F2-F3 fibrosis, semaglutide's positive phase 3 in MASH, plus pioglitazone, bariatric surgery, and liver transplantation in this population.
• 
  MASLD with Sven Francque - Part 1 26.05.2026 25mnt

  Around one in three adults has MASLD, but only a few percent reach cirrhosis. Pradeep Mundre and Professor Sven Francque (Antwerp), co-author of the 2024 EASL guidelines, cover the new nomenclature, dysfunctional adiposity versus BMI, and how to use FIB-4 to decide who needs a hepatologist.
• 
  UEG Online Courses x UEG Podcast: Consequences of proctology surgery (LARS) 12.05.2026 19mnt

  Sphincter-preserving surgery spares most rectal cancer patients a stoma, but hands many of them low anterior resection syndrome (LARS). Three European surgeons join Harald Rosen in discussing follow-up, where transanal irrigation lands, when to involve the gastroenterologist, and where sacral neuromodulation fits.
• 
  EoE with Alex Straumann - Part 2 28.04.2026 15mnt

  EoE requires long-term management, but what does that look like in practice? In Part 2, Prof. Alex Straumann discusses the realities of treating a chronic, relapsing disease, where remission is achievable but a cure is not. The episode explores how to approach maintenance therapy, manage persistent symptoms despite histological remission, and when to escalate treatment to biologics. It also addresses the practical limitations of dietary strategies and the ongoing challenge of identifying trigger foods. Looking ahead, the discussion highlights key unmet needs in EoE, including the absence of reliable diagnostic tools for food triggers and the potential influence of modern food production on disease prevalence.
• 
  EoE with Alex Straumann - Part 1 21.04.2026 23mnt

  Part 2 will be released on Wednesday, the 29th of April. Eosinophilic oesophagitis (EoE) is now a well-recognised condition. But it was not always so. In this episode, Prof. Alex Straumann shares how EoE was first identified, taking us back to the late 1980s when unusual cases of food impaction and eosinophilic inflammation did not fit any known diagnosis. He discusses the clinical observations that led to recognising EoE as a distinct disease, the early case series that defined its phenotype, and the initial treatment approaches that shaped current practice. The episode also addresses key diagnostic challenges that remain relevant today, including the distinction from oesophageal eosinophilia and the limitations of symptom-based assessment.
• 
  IBD malignancy with Hannah Gordon 07.04.2026 43mnt

  In this episode, Pradeep Mundre speaks with Hannah Gordon about one of the most challenging areas in inflammatory bowel disease management: balancing effective treatment with cancer risk. As therapeutic options expand, clinicians increasingly face complex scenarios involving patients with prior malignancy in remission or those undergoing active cancer treatment. The discussion examines how cancer risk relates both to IBD itself and to immunosuppressive or biologic therapies. The episode highlights limitations in current evidence, differences across drug classes, and the importance of individualised decision-making. Emphasis is placed on multidisciplinary collaboration, patient communication, and navigating uncertainty in real-world clinical practice.
• 
  Nutrition in coeliac disease for a clinician with Cristian Costas 17.03.2026 40mnt

  Cristian Costas, a leading dietitian in coeliac disease, shares insights on managing celiac disease through diet, setting up specialised services, and navigating dietary challenges. We explore diagnosis, implementation of a gluten-free diet, and strategies to improve patient outcomes.
• 
  Part 2: Nageshwar Reddy - How endoscopy has changed 03.03.2026 22mnt

  In the second part of this in-depth conversation, host Egle Dieninyte continues her discussion with Professor Nageshwar Reddy, shifting the focus from technological innovation to ethics, responsibility and the human dimension of endoscopy. Professor Reddy shares how mobile endoscopy units have brought life-saving care to rural populations, and why cascade hygiene strategies are sometimes necessary when resources are limited. The conversation then turns to a topic rarely discussed openly: mistakes. What constitutes a true medical mistake? How do we distinguish adverse events from preventable errors? And why should ERCP only ever be performed with strict indication? Finally, Professor Reddy reflects on mentorship, generational change, work–home balance, and why compassion is not an innate trait — but a skill that can and must be cultivated. A powerful conclusion to a two-part conversation on what it really means to practise endoscopy.
• 
  Part 1: Nageshwar Reddy - How endoscopy has changed 24.02.2026 28mnt

  What has truly transformed endoscopy over the past decades? In this first part of a two-part conversation, host Egle Dieninyte sits down with Professor Nageshwar Reddy, one of the most influential pioneers in modern therapeutic endoscopy, to reflect on how the field has evolved — and where it is heading next. From the transition from rigid to fibreoptic endoscopy, to the introduction of video systems that reshaped team dynamics in the endoscopy suite, Professor Reddy explains why some of the most powerful innovations were not necessarily the most glamorous ones. The discussion also explores: • Disposable scopes and environmental responsibility • Antibiotic resistance and global practice differences • The role of passion and compassion in medicine • Regenerative endoscopy and stem cell applications • The story behind the “Nagi stent” Beyond technology, this episode offers a personal perspective on success, mentorship, and what it truly means to be a good endoscopist. 🎧 Listen now to Part 1 — and stay tuned for Part 2, which will be released in a week from now on the 4th of March.
• 
  UEG Online Courses x UEG Podcast: Impact of polyp detection in colonoscopy 10.02.2026 39mnt

  - What happens when optical diagnosis and histology don’t align? - Does better polyp detection always mean better outcomes? - And how should AI, quality metrics and surveillance intervals really shape daily endoscopy practice? In this special episode, we share an unfiltered round-table discussion recorded during the UEG Online Course on the impact of polyp detection in colonoscopy. Leading experts Raf Bisschops, Manuele Furnari, Veronique Van der Voort and Pieter Sinonquel debate real-world dilemmas around serrated lesions, pathology discordance, documentation, bowel preparation and the clinical consequences of rising ADRs. Also watch it as a video podcast on Spotify Listen now and explore the full course for free (login required) on gutflix.eu: [The impact of polyp detection in colonoscopy](https://gutflix.eu/r/i6GfsYAhus8u)
• 
  Coeliac disease with David Sanders 27.01.2026 45mnt

  In this episode of the UEG Podcast, host Pradeep Mundre is joined by David Sanders, Professor of Gastroenterology at Sheffield and one of the world’s leading experts in coeliac disease. Timed with the recent update of the British Society of Gastroenterology coeliac guidelines, the discussion explores why coeliac disease remains frequently underdiagnosed, even in specialist care. Together, they unpack the latest evidence on serology-based diagnosis, optimal biopsy strategies, potential and seronegative coeliac disease, and when HLA testing is truly useful. The episode also covers long-term follow-up, the role of repeat biopsies, ultra-short coeliac disease, and emerging non-dietary therapies — including the realistic prospects of a future “pizza pill”. Check out the newest guidelines on coeliac disease here:https://doi.org/10.1002/ueg2.70119
• 
  The future of immunotherapy → are surgeons obsolete soon? with Jeroen Dekervel 13.01.2026 40mnt

  Immunotherapy might be revolutionising the way we fight GI cancers. In our latest episode, we dive into how this innovative treatment is changing patient outcomes and the role it plays in cancer management. To discuss this, we talked to Jeroen Dekervel, gastroenterologist and oncologist at the UZ Leuven in Belgium. Our host, Pradeep Mundre guides us through the conversation about how tumours develop a resistance to chemotherapy, the quality of life for oncological patients, and why the term "palliative treatment" for cancer patients could use an update.
• 
  Under Pressure with Lina Sopiene 16.12.2025 23mnt

  In this thought-provoking episode of the UEG Podcast, host Egle Dieninyte sits down with organisational psychologist Lina Sopiene to explore one of medicine’s most unspoken challenges — burnout. Together, they unpack why high-achieving healthcare professionals often equate self-worth with performance, how this mindset fuels exhaustion, and what practical steps can help doctors and nurses reconnect with themselves. From learning to “be a human being, not just a human doing” to managing workplace anger and setting healthy boundaries, this conversation is a candid look at the emotional realities of hospital life. Lina offers grounded, compassionate insights on self-care, emotional regulation, and the art of saying no — lessons that every healthcare worker can relate to. Honest, empathetic, and deeply relevant — a must-listen for anyone navigating the pressures of modern medicine.
• 
  Pancreatic cystic neoplasms with Marco del Chiaro 02.12.2025 21mnt

  This episode of the UEG Podcast takes place at the EPC meeting in the summer of 2025. Our host Egle Dieninyte sits down with Professor Marco Del Chiaro, Surgical Oncologist and global lead of the upcoming Guidelines on Pancreatic Cystic Neoplasms. Tune in as they discuss why a unified, evidence-based approach is essential in this complex field, the challenges of managing cystic pancreatic lesions with limited high-quality data, and the balance between clinical judgement and guideline recommendations. Professor Del Chiaro also reflects on the limitations of current evidence, the evolving role of biomarkers, and how collaboration across continents may finally help standardise diagnosis, surveillance, and treatment for these patients. Insightful, candid, and forward-looking — this episode offers a rare behind-the-scenes view into how global consensus in pancreatic disease is built.
• 
  Best of UEG Week - Nursing with Mary Phillips and Leigh Donnelly 18.11.2025 22mnt

  In this episode of the UEG Podcast, Mary Phillips and Leigh Donnelly reflect on the highlights of UEG Week 2025 in Berlin from a nursing and allied healthcare perspective. They discuss the most inspiring sessions from learning through mistakes in “Never Waste a Good Disaster” to the growing focus on sustainability, green endoscopy, and global health. The conversation also touches on caring for trans patients in gastroenterology, tackling fake news in dietetics, and understanding the clinical impact of GLP-1 medications and pancreatic cancer research. With insights on teamwork, education, and the value of multidisciplinary collaboration, this episode celebrates the essential role of nurses and allied health professionals in advancing digestive health care.
• 
  Best of UEG Week - HPB with Carolin Schneider 11.11.2025 14mnt

  In this episode, UEG's new Scientific Committee chair Jörn Schattenberg and Carolin Schneider, UEG rising start of 2025, recap the standout science from UEG Week 2025 in Berlin. They discuss highlights from the HPB field, including pivotal phase III data on linerixibat for cholestatic pruritus in PBC, advances in MASLD/MASH therapies such as FGF21 analogues and resmetirom, and new insights into liquid biopsy and AI-assisted imaging for pancreatic lesions. The conversation also explores simvastatin’s potential in preventing recurrent pancreatitis and reflects on the value of collaboration, precision medicine, and prospective clinical trials showcased at UEG Week.